FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034489347> ?p ?o ?g. }

• W2034489347 endingPage "e108240" @default.
• W2034489347 startingPage "e108240" @default.
• W2034489347 abstract "This study aimed to investigate the effects of combined atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in apolipoproteinE (apoE) knockout mice.Forty male, apoE-/- mice were fed a high-fat diet for 16 weeks. Thereafter, while maintained on high-fat diet, they were randomized into four (n = 10) groups for 8 additional weeks: Group CO: Control. Group AT: Atorvastatin treatment (10 mg/Kg/day). Group EX: Exercise-training on treadmill. Group AT+EX: Atorvastatin and simultaneous exercise training. At the study's end, plasma cholesterol levels, lipids and triglycerides were measured, along with the circulating concentrations of matrix-metalloproteinases (MMP-2,3,8,9) and their inhibitors (TIMP-1,2,3). Plaque area and the relative concentrations of collagen, elastin, macrophages, smooth muscle cells, MMP-2,3,8,9 and TIMP-1,2,3 within plaques were determined. Lastly, MMP activity was assessed in the aortic arch.All intervention groups showed a lower degree of lumen stenosis, with atheromatous plaques containing more collagen and elastin. AT+EX group had less stenosis and more elastin compared to single intervention groups. MMP-3,-8 -9 and macrophage intra-plaque levels were reduced in all intervention groups. EX group had increased TIMP-1 levels within the lesions, while TIMP-2 was decreased in all intervention groups. The blood levels of the above molecules increased during atherosclerosis development, but they did not change after the therapeutic interventions in accordance to their intra-plaque levels.The two therapeutic strategies act with synergy regarding the extent of the lesions and lumen stenosis. They stabilize the plaque, increasing its content in elastin and collagen, by influencing the MMP/TIMP equilibrium, which is mainly associated with the macrophage amount. While the increased MMP-2,-3,-8 -9, as well as TIMP-1 and TIMP-2 circulating levels are markers of atherosclerosis, they are not correlated with their corresponding concentrations within the lesions after the therapeutic interventions, and cannot serve as markers for the disease development/amelioration." @default.
• W2034489347 created "2016-06-24" @default.
• W2034489347 creator A5003003528 @default.
• W2034489347 creator A5019793729 @default.
• W2034489347 creator A5030182801 @default.
• W2034489347 creator A5057845695 @default.
• W2034489347 creator A5062733088 @default.
• W2034489347 creator A5066707911 @default.
• W2034489347 creator A5080141249 @default.
• W2034489347 creator A5086293816 @default.
• W2034489347 date "2014-09-29" @default.
• W2034489347 modified "2023-10-13" @default.
• W2034489347 title "The Complementary Effects of Atorvastatin and Exercise Treatment on the Composition and Stability of the Atherosclerotic Plaques in ApoE Knockout Mice" @default.
• W2034489347 cites W1499787953 @default.
• W2034489347 cites W1967255096 @default.
• W2034489347 cites W1974187375 @default.
• W2034489347 cites W1976085342 @default.
• W2034489347 cites W1981100594 @default.
• W2034489347 cites W1988604211 @default.
• W2034489347 cites W1998351741 @default.
• W2034489347 cites W2002537705 @default.
• W2034489347 cites W2005935529 @default.
• W2034489347 cites W2006225546 @default.
• W2034489347 cites W2017886856 @default.
• W2034489347 cites W2042377649 @default.
• W2034489347 cites W2049806369 @default.
• W2034489347 cites W2062785036 @default.
• W2034489347 cites W2063842926 @default.
• W2034489347 cites W2065194546 @default.
• W2034489347 cites W2070410944 @default.
• W2034489347 cites W2070452608 @default.
• W2034489347 cites W2074467917 @default.
• W2034489347 cites W2075995458 @default.
• W2034489347 cites W2093133341 @default.
• W2034489347 cites W2101141212 @default.
• W2034489347 cites W2101665468 @default.
• W2034489347 cites W2104364881 @default.
• W2034489347 cites W2105520838 @default.
• W2034489347 cites W2105924650 @default.
• W2034489347 cites W2110171695 @default.
• W2034489347 cites W2114280375 @default.
• W2034489347 cites W2123353784 @default.
• W2034489347 cites W2124404919 @default.
• W2034489347 cites W2127832353 @default.
• W2034489347 cites W2129701980 @default.
• W2034489347 cites W2132901141 @default.
• W2034489347 cites W2140964702 @default.
• W2034489347 cites W2141910805 @default.
• W2034489347 cites W2148463229 @default.
• W2034489347 cites W2151531354 @default.
• W2034489347 cites W2154401382 @default.
• W2034489347 cites W2165351280 @default.
• W2034489347 cites W2317692140 @default.
• W2034489347 doi "https://doi.org/10.1371/journal.pone.0108240" @default.
• W2034489347 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4180453" @default.
• W2034489347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25264981" @default.
• W2034489347 hasPublicationYear "2014" @default.
• W2034489347 type Work @default.
• W2034489347 sameAs 2034489347 @default.
• W2034489347 citedByCount "23" @default.
• W2034489347 countsByYear W20344893472015 @default.
• W2034489347 countsByYear W20344893472016 @default.
• W2034489347 countsByYear W20344893472017 @default.
• W2034489347 countsByYear W20344893472018 @default.
• W2034489347 countsByYear W20344893472019 @default.
• W2034489347 countsByYear W20344893472020 @default.
• W2034489347 countsByYear W20344893472021 @default.
• W2034489347 countsByYear W20344893472022 @default.
• W2034489347 countsByYear W20344893472023 @default.
• W2034489347 crossrefType "journal-article" @default.
• W2034489347 hasAuthorship W2034489347A5003003528 @default.
• W2034489347 hasAuthorship W2034489347A5019793729 @default.
• W2034489347 hasAuthorship W2034489347A5030182801 @default.
• W2034489347 hasAuthorship W2034489347A5057845695 @default.
• W2034489347 hasAuthorship W2034489347A5062733088 @default.
• W2034489347 hasAuthorship W2034489347A5066707911 @default.
• W2034489347 hasAuthorship W2034489347A5080141249 @default.
• W2034489347 hasAuthorship W2034489347A5086293816 @default.
• W2034489347 hasBestOaLocation W20344893471 @default.
• W2034489347 hasConcept C126322002 @default.
• W2034489347 hasConcept C134018914 @default.
• W2034489347 hasConcept C142724271 @default.
• W2034489347 hasConcept C185592680 @default.
• W2034489347 hasConcept C2777482532 @default.
• W2034489347 hasConcept C2778163477 @default.
• W2034489347 hasConcept C2779134260 @default.
• W2034489347 hasConcept C2779869378 @default.
• W2034489347 hasConcept C57089818 @default.
• W2034489347 hasConcept C71924100 @default.
• W2034489347 hasConceptScore W2034489347C126322002 @default.
• W2034489347 hasConceptScore W2034489347C134018914 @default.
• W2034489347 hasConceptScore W2034489347C142724271 @default.
• W2034489347 hasConceptScore W2034489347C185592680 @default.
• W2034489347 hasConceptScore W2034489347C2777482532 @default.
• W2034489347 hasConceptScore W2034489347C2778163477 @default.
• W2034489347 hasConceptScore W2034489347C2779134260 @default.
• W2034489347 hasConceptScore W2034489347C2779869378 @default.
• W2034489347 hasConceptScore W2034489347C57089818 @default.

• next